Skip to main content

Oxford Cannabinoid Technologies "proceeding forward as planned" after review meeting

Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTCQB:OCTHF) CEO Clarissa Sowemimo-Coker speaks to Proactive after announcing that a Research Ethics Committee (REC) review meeting for its lead programme OCT461201 has now taken place. Sowemimo-Coker says the company is "proceeding forward as planned" and has "hit the ground running" in 2023.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  204.88
-2.09 (-1.01%)
AAPL  279.76
+6.08 (2.22%)
AMD  213.44
-0.13 (-0.06%)
BAC  54.72
-0.67 (-1.22%)
GOOG  312.80
-5.83 (-1.83%)
META  670.38
-0.34 (-0.05%)
MSFT  403.79
-9.48 (-2.30%)
NVDA  191.58
+3.04 (1.61%)
ORCL  156.45
-3.44 (-2.15%)
TSLA  425.50
+0.29 (0.07%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.